Plus Therapeutics to become Cerenome, to trade under new Nasdaq ticker CNSY on August 3, 2026< Affirms 2026 guidance on key ...

Replimune Group, Inc. nears a pivotal FDA AdCom for RP1 ahead of an Aug 2, 2026 decision. Click for this REPLY stock update ...

On football Twitter, terms like ‘Brexit football’, ‘Barclaysman’ and ‘the streets won’t forget’ are getting thrown about all ...

(Nasdaq: GILD) today announced that the U.S. Food and Drug Administration (FDA) has approved Trodelvy ® (sacituzumab govitecan-hziy), a first-in-class Trop-2-directed antibody-drug conjugate (ADC), ...

NeuroSense Therapeutics Ltd. ("NeuroSense"), a late-clinical stage biotechnology company developing novel treatments for severe neurodegenerative diseases, today announced positive biomarker findings ...

Detailed price information for Greenwich Lifesciences Inc (GLSI-Q) from The Globe and Mail including charting and trades.

The triangle taught me how to think about information security. The pentagon taught me how to think about organizational ...

A new international expert consensus document refines and updates how heart failure is identified and classified, aiming to ...

The British eventing squad shortlist for the 2026 World Championships in Aachen (11 to 23 August) has been revealed, ...

Amidation of the C-terminal carboxylic group of QYNAD completely abolished its activity, whereas acylation of the N-terminal amino group caused only a minor reduction of its channel-blocking activity.

The phenomenon of a Full Moon arises when our planet, Earth, is precisely sandwiched between the Sun and the Moon. This alignment ensures the entire side of the Moon that faces us gleams under ...

Heart failure (HF) remains a pressing health concern, with rising prevalence globally. Subjectivity and ambiguity in the ...